PA
ITCI
Perceptive Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-786,358
| Closed | -$104M | – | 105 |
|
|
2025
Q1 | $104M | Sell |
786,358
-501,970
| -39% | -$66.2M | 3.66% | 8 |
|
|
2024
Q4 | $108M | Sell |
1,288,328
-333,887
| -21% | -$27.9M | 2.97% | 8 |
|
|
2024
Q3 | $119M | Sell |
1,622,215
-94,192
| -5% | -$6.89M | 2.51% | 9 |
|
|
2024
Q2 | $118M | Buy |
1,716,407
+661,052
| +63% | +$45.3M | 2.83% | 9 |
|
|
2024
Q1 | $73M | Buy |
1,055,355
+947,355
| +877% | +$65.6M | 1.28% | 26 |
|
|
2023
Q4 | $7.73M | Buy |
+108,000
| New | +$7.73M | 0.17% | 67 |
|
|
2023
Q3 | – | Sell |
-245,800
| Closed | -$15.6M | – | 101 |
|
|
2023
Q2 | $15.6M | Buy |
+245,800
| New | +$15.6M | 0.45% | 56 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 127 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 121 |
|
|
2018
Q2 | – | Sell |
-70,000
| Closed | -$1.47M | – | 144 |
|
|
2018
Q1 | $1.47M | Buy |
+70,000
| New | +$1.47M | 0.04% | 95 |
|
|
2017
Q4 | – | Sell |
-929,460
| Closed | -$14.7M | – | 149 |
|
|
2017
Q3 | $14.7M | Buy |
+929,460
| New | +$14.7M | 0.56% | 44 |
|